Your search returned 11 results.

Results
	1.	Formulation considerations for the development of medications with abuse potential. [electronic resource] by Mansbach, Robert S Moore, Richard A Producer: 20060725 In: Drug and alcohol dependence vol. 83 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Incorporating the assessment of abuse liability into the drug discovery and development process. [electronic resource] by Mansbach, Robert S Feltner, Douglas E Gold, Lisa H Schnoll, Sidney H Producer: 20040204 In: Drug and alcohol dependence vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101 606 in rats and rhesus monkeys. [electronic resource] by Nicholson, Katherine L Mansbach, Robert S Menniti, Frank S Balster, Robert L Producer: 20080124 In: Behavioural pharmacology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. [electronic resource] by Mansbach, Robert S Ludington, Elizabeth Rogowski, Roberta Kittrelle, Jeffrey P Jochelson, Philip Producer: 20111118 In: Clinical therapeutics vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	The role of adverse events and related safety data in the pre-market evaluation of drug abuse potential. [electronic resource] by Mansbach, Robert S Schoedel, Kerri A Kittrelle, Jeffrey P Sellers, Edward M Producer: 20110620 In: Drug and alcohol dependence vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Significantly Improved Pharmacokinetics Enhances [electronic resource] by Zhao, Yanan Lee, Min Hee Paderu, Padmaja Lee, Annie Jimenez-Ortigosa, Cristina Park, Steven Mansbach, Robert S Shaw, Karen Joy Perlin, David S Producer: 20190930 In: Antimicrobial agents and chemotherapy vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Synthesis and SAR of 2-aryloxy-4-alkoxy-pyridines as potent orally active corticotropin-releasing factor 1 receptor antagonists. [electronic resource] by Chen, Yuhpyng L Braselton, John Forman, James Gallaschun, Randall J Mansbach, Robert Schmidt, Anne W Seeger, Thomas F Sprouse, Jeff S Tingley, F David Winston, Elizabeth Schulz, David W Producer: 20080605 In: Journal of medicinal chemistry vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel report. [electronic resource] by Grudzinskas, Charles Balster, Robert L Gorodetzky, Charles W Griffiths, Roland R Henningfield, Jack E Johanson, Chris-Ellyn Mansbach, Robert S McCormick, Cynthia G Schnoll, Sidney H Strain, Eric C Wright, C Producer: 20060725 In: Drug and alcohol dependence vol. 83 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonists. [electronic resource] by Chen, Yuhpyng L Obach, R Scott Braselton, John Corman, Michael L Forman, James Freeman, Jody Gallaschun, Randall J Mansbach, Robert Schmidt, Anne W Sprouse, Jeffrey S Tingley Iii, F David Winston, Elizabeth Schulz, David W Producer: 20080605 In: Journal of medicinal chemistry vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation. [electronic resource] by Coe, Jotham W Brooks, Paige R Wirtz, Michael C Bashore, Crystal G Bianco, Krista E Vetelino, Michael G Arnold, Eric P Lebel, Lorraine A Fox, Carol B Tingley, F David Schulz, David W Davis, Thomas I Sands, Steven B Mansbach, Robert S Rollema, Hans O'Neill, Brian T Producer: 20051223 In: Bioorganic & medicinal chemistry letters vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. [electronic resource] by Coe, Jotham W Brooks, Paige R Vetelino, Michael G Wirtz, Michael C Arnold, Eric P Huang, Jianhua Sands, Steven B Davis, Thomas I Lebel, Lorraine A Fox, Carol B Shrikhande, Alka Heym, James H Schaeffer, Eric Rollema, Hans Lu, Yi Mansbach, Robert S Chambers, Leslie K Rovetti, Charles C Schulz, David W Tingley, F David O'Neill, Brian T Producer: 20050607 In: Journal of medicinal chemistry vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)